Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
699.18B | 422.16B | 451.95B | 446.87B | 62.83B | Gross Profit |
186.98B | 105.79B | 121.98B | 141.15B | 19.01B | EBIT |
113.81B | 67.24B | 83.09B | 102.85B | 13.60B | EBITDA |
169.01B | 93.41B | 118.52B | 134.50B | 18.62B | Net Income Common Stockholders |
153.81B | 10.31B | 6.04B | 39.95B | 17.13B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
8.55B | 6.73B | 15.29B | 10.27B | 6.60B | Total Assets |
1.41T | 638.84B | 631.83B | 204.24B | 107.09B | Total Debt |
174.09B | 151.36B | 68.00B | 5.50B | 10.52B | Net Debt |
166.11B | 146.33B | 65.93B | 4.86B | 10.12B | Total Liabilities |
615.21B | 344.62B | 270.76B | 63.00B | 38.57B | Stockholders Equity |
793.34B | 294.24B | 360.46B | 140.92B | 68.10B |
Cash Flow | Free Cash Flow | |||
51.67B | 48.98B | 65.89B | 48.30B | 3.90B | Operating Cash Flow |
124.72B | 85.03B | 97.66B | 91.29B | 18.45B | Investing Cash Flow |
-72.89B | -35.83B | -14.69B | -53.65B | -2.36B | Financing Cash Flow |
-48.27B | -41.09B | -77.17B | -53.14B | -19.74B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $1.58B | 9.23 | 24.53% | ― | -42.74% | 242.59% | |
75 Outperform | £59.74B | 17.57 | 16.07% | 1.95% | 1.78% | 15.53% | |
72 Outperform | $30.77B | 34.00 | 11.79% | 0.79% | -4.68% | -1.73% | |
66 Neutral | $8.58B | 9.14 | 8.39% | 1.09% | -5.07% | 417.07% | |
66 Neutral | $7.36B | 15.79 | 33.51% | 0.45% | 0.64% | -1.15% | |
63 Neutral | $29.15B | 14.76 | 22.83% | 0.64% | -3.56% | 70.93% | |
47 Neutral | $2.65B | -3.07 | -22.25% | 3.27% | 3.70% | -29.53% |